ArticleBiochemistry and biophysics reports2026
DCAF7 enhances atherosclerosis in vascular endothelial cells by promoting SLC40A1 transcription through facilitating TNF-mediated NF-κB function.
Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atherosclerosis (AS) poses a significant risk to human health. Our study, through the analysis of publicly available datasets, discovered that apoptosis plays a crucial role in the development of atherosclerosis. Additionally, we found that the iron apoptosis factor SLC40A1 is greatly increased, while the up-regulation of DCAF7 may be a significant contributing element to this impact. Therefore, we conducted tests both in vivo and in vitro to show that DCAF7 has the ability to influence the expression of SLC40A1 by impacting TNF and controlling the function of NF-κB, resulting in apoptosis. Following the creation of ApoE-/- mice, we suppressed the activity of DCAF7 and observed a substantial reduction in the advancement of carotid atherosclerosis and apoptosis in these animals. This suggests that DCAF7 plays a crucial role in the development of carotid atherosclerosis. Targeting DCAF7 has the potential to halt the progression of atherosclerosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.